1
项与 Anti-CD177 CAR-T (Shenzhen Geno-Immune Medical ) 相关的临床试验 / Unknown status临床1/2期IIT Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas
The aim of this clinical trial is to assess the feasibility, safety and efficacy of CAR T cells immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy that combines CAR T cells and IgT cells to treat sarcoma.
100 项与 Anti-CD177 CAR-T (Shenzhen Geno-Immune Medical ) 相关的临床结果
100 项与 Anti-CD177 CAR-T (Shenzhen Geno-Immune Medical ) 相关的转化医学
100 项与 Anti-CD177 CAR-T (Shenzhen Geno-Immune Medical ) 相关的专利(医药)
100 项与 Anti-CD177 CAR-T (Shenzhen Geno-Immune Medical ) 相关的药物交易